Full Text
The Value Of Progression-Free Survival (Pfs) As An Endpoint In Oncology Trials

Abstract

Authors

C Quinn S Palmer J Bruns C Grant D Sykes S Kaura

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×